PMID- 19540623 OWN - NLM STAT- MEDLINE DCOM- 20110817 LR - 20211020 IS - 1558-1497 (Electronic) IS - 0197-4580 (Print) IS - 0197-4580 (Linking) VI - 32 IP - 5 DP - 2011 May TI - beta-Amyloid impairs axonal BDNF retrograde trafficking. PG - 821-33 LID - 10.1016/j.neurobiolaging.2009.05.012 [doi] AB - The neurotrophin, brain-derived neurotrophic factor (BDNF), is essential for synaptic function, plasticity and neuronal survival. At the axon terminal, when BDNF binds to its receptor, tropomyosin-related kinase B (TrkB), the signal is propagated along the axon to the cell body, via retrograde transport, regulating gene expression and neuronal function. Alzheimer disease (AD) is characterized by early impairments in synaptic function that may result in part from neurotrophin signaling deficits. Growing evidence suggests that soluble beta-amyloid (Abeta) assemblies cause synaptic dysfunction by disrupting both neurotransmitter and neurotrophin signaling. Utilizing a novel microfluidic culture chamber, we demonstrate a BDNF retrograde signaling deficit in AD transgenic mouse neurons (Tg2576) that can be reversed by gamma-secretase inhibitors. Using BDNF-GFP, we show that BDNF-mediated TrkB retrograde trafficking is impaired in Tg2576 axons. Furthermore, Abeta oligomers alone impair BDNF retrograde transport. Thus, Abeta reduces BDNF signaling by impairing axonal transport and this may underlie the synaptic dysfunction observed in AD. CI - Published by Elsevier Inc. FAU - Poon, Wayne W AU - Poon WW AD - Institute for Brain Aging and Dementia, University of California, Irvine, 1226 Gillespie NRF, Irvine, CA 92697, United States. wpoon@uci.edu FAU - Blurton-Jones, Mathew AU - Blurton-Jones M FAU - Tu, Christina H AU - Tu CH FAU - Feinberg, Leila M AU - Feinberg LM FAU - Chabrier, Meredith A AU - Chabrier MA FAU - Harris, Joe W AU - Harris JW FAU - Jeon, Noo Li AU - Jeon NL FAU - Cotman, Carl W AU - Cotman CW LA - eng GR - T32 AG000096-29/AG/NIA NIH HHS/United States GR - AG029378/AG/NIA NIH HHS/United States GR - P01 AG000538/AG/NIA NIH HHS/United States GR - P50 AG016573-01A1/AG/NIA NIH HHS/United States GR - K01 AG029378-03/AG/NIA NIH HHS/United States GR - AG016573/AG/NIA NIH HHS/United States GR - P50 AG016573/AG/NIA NIH HHS/United States GR - K01 AG029378/AG/NIA NIH HHS/United States GR - P50 AG016573-12/AG/NIA NIH HHS/United States GR - AG00538/AG/NIA NIH HHS/United States GR - T32 AG000096/AG/NIA NIH HHS/United States GR - AG000096/AG/NIA NIH HHS/United States GR - K01 AG029378-02/AG/NIA NIH HHS/United States GR - K01 AG029378-01A2/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20090621 PL - United States TA - Neurobiol Aging JT - Neurobiology of aging JID - 8100437 RN - 0 (Amyloid beta-Peptides) RN - 0 (Brain-Derived Neurotrophic Factor) RN - EC 2.7.10.1 (Receptor, trkB) RN - EC 3.4.- (Amyloid Precursor Protein Secretases) SB - IM MH - Alzheimer Disease/drug therapy/*metabolism MH - Amyloid Precursor Protein Secretases/antagonists & inhibitors MH - Amyloid beta-Peptides/*metabolism MH - Animals MH - Axonal Transport/drug effects/*physiology MH - Axons/drug effects/*metabolism MH - Brain-Derived Neurotrophic Factor/*metabolism MH - Cell Culture Techniques MH - Mice MH - Mice, Transgenic MH - Microfluidics MH - Protein Transport MH - Receptor, trkB/metabolism PMC - PMC3038182 MID - NIHMS244888 EDAT- 2009/06/23 09:00 MHDA- 2011/08/19 06:00 PMCR- 2012/05/01 CRDT- 2009/06/23 09:00 PHST- 2008/06/26 00:00 [received] PHST- 2009/05/07 00:00 [revised] PHST- 2009/05/08 00:00 [accepted] PHST- 2009/06/23 09:00 [entrez] PHST- 2009/06/23 09:00 [pubmed] PHST- 2011/08/19 06:00 [medline] PHST- 2012/05/01 00:00 [pmc-release] AID - S0197-4580(09)00168-7 [pii] AID - 10.1016/j.neurobiolaging.2009.05.012 [doi] PST - ppublish SO - Neurobiol Aging. 2011 May;32(5):821-33. doi: 10.1016/j.neurobiolaging.2009.05.012. Epub 2009 Jun 21.